Prévisions du marché des kits de tests rapides en Amérique du Sud et centrale jusqu’en 2030 – Analyse régionale – par type (tests rapides d’antigènes, tests rapides d’anticorps et autres), produit (kit de tests rapides en vente libre et kit de tests rapides professionnels), technologie (latéral Test de flux, phase solide, agglutination, test immunospot et basé sur les composants cellulaires), application (test de glycémie, test de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques et autres) et utilisateur final (hôpital et cliniques, soins à domicile, Centres de diagnostic et autres)
La préférence croissante pour les techniques de PCR renforce le marché des kits de test rapide en Amérique du Sud et en Amérique centrale
Au cours des dernières années, les méthodes moléculaires telles que la PCR sont devenus des outils de diagnostic plus efficaces, car ils facilitent le diagnostic précis d’un large éventail de maladies infectieuses. La plupart des tests moléculaires populaires utilisent la réaction en chaîne par polymérase à transcription inverse (RT-PCR). La technique fournit des résultats reproductibles, comparables entre différents laboratoires et donc acceptés dans le monde entier. Les fabricants sont impliqués dans les nouveaux développements de PCR.
Par exemple, GeneSoC est un système récemment développé dans lequel les solutions de réaction PCR sont entraînées réciproquement sur de nombreuses zones préchauffées et encapsulées sur une puce dans un canal d\'écoulement extrêmement fin. GeneSoC est disponible pour la PCR multiplex en temps réel et est capable de détecter simultanément 3 canaux de fluorescence. Elle est considérée comme une excellente technologie de diagnostic alternative pour la détection des virus grippaux A et B, car elle réalise la réaction RT-PCR en temps réel en environ 16 minutes. En outre, l\'application des technologies PCR augmente également dans les domaines de la microbiologie clinique, de la virologie, de la parasitologie, de la biotechnologie et des domaines connexes en raison du dépistage simple, rapide et hautement spécifique rendu possible par cet outil. Ainsi, la préférence croissante pour la PCR en tant qu’outil diagnostique et clinique devrait offrir des opportunités lucratives au marché des kits de tests rapides au cours de la période de prévision.
Aperçu du marché des kits de test rapide en Amérique du Sud et en Amérique centrale
Selon l\'Organisation mondiale de la santé (OMS), le Brésil fait partie des 20 pays avec un taux de tuberculose élevé. Le Brésil représentait 33 % du total des cas signalés en 2020. En 2021, le Brésil a enregistré 68 271 nouveaux cas de tuberculose, ce qui correspond à un taux d’incidence de 32 cas pour 100 000 habitants. L\'incidence de la tuberculose augmente lentement en raison d\'une tendance à la hausse au Brésil. Au Brésil, le test Xpert MTB/RIF, un test moléculaire rapide pour la tuberculose (RMT-TB), est utilisé pour diagnostiquer de nouveaux cas de tuberculose pulmonaire et laryngée chez les adultes et les adolescents.
Pendant la pandémie de COVID-19 au Brésil, le ministère de la Santé du pays a distribué environ un tiers des 22,9 millions de kits de test RT-PCR. Le gouvernement fédéral a fourni 6,43 millions de tests PCR en temps réel pour détecter le SRAS-CoV-2 dans les États. Plusieurs acteurs au Brésil sont impliqués dans la fabrication de kits de tests rapides. Ainsi, les facteurs susmentionnés sont susceptibles de contribuer à la croissance rapide du marché des kits de tests.
Chiffre d\'affaires et prévisions du marché des kits de test rapide en Amérique du Sud et centrale jusqu\'en 2030 (millions de dollars américains)
Segmentation du marché des kits de test rapide en Amérique du Sud et centrale
Amérique du Sud et centrale Le marché des kits de test rapide est segmenté en fonction du type, du produit, de la technologie, de l’application, de l’utilisateur final et du pays. En fonction du type, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est segmenté en tests rapides d’antigènes, tests rapides d’anticorps et autres. Le segment des tests rapides d\'antigène détenait la plus grande part de marché en 2022.
En termes de produits, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est divisé en kit de test rapide en vente libre et en kit de test rapide professionnel. Le segment des kits de test rapide en vente libre détenait une part de marché plus importante en 2022.
Par technologie, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est segmenté en test à flux latéral, phase solide, agglutination, test immunospot. , et basé sur des composants cellulaires. Le segment des tests à flux latéral détenait la plus grande part de marché en 2022.
Sur la base des applications, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est classé en tests de glycémie, tests de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques, et d\'autres. Le segment des tests de glycémie détenait la plus grande part de marché en 2022.
En termes d\'utilisateur final, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est segmenté en hôpitaux et cliniques, soins à domicile, centres de diagnostic et autres. Le segment des hôpitaux et des cliniques détenait la plus grande part de marché en 2022.
En fonction du pays, le marché des kits de test rapide en Amérique du Sud et en Amérique centrale est segmenté entre le Brésil, l\'Argentine et le reste de l\'Amérique du Sud et centrale. Le Brésil a dominé la part de marché des kits de tests rapides en Amérique du Sud et en Amérique centrale en 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratoriess, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd , Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA et Beckman Coulter Inc sont quelques-uns des principaux acteurs opérant sur le marché des kits de tests rapides en Amérique du Sud et en Amérique centrale.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - South & Central America Market Analysis
5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Rapid Test Kits Market - Country Analysis
11.1 South & Central America
11.1.1 Overview
11.1.2 South & Central America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.2.1 Brazil
11.1.2.1.1 Overview
11.1.2.2 Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.2.1 Brazil: Rapid Test Kits Market Breakdown, by Type
11.1.2.2.2 Brazil: Rapid Test Kits Market Breakdown, by Product
11.1.2.2.3 Brazil: Rapid Test Kits Market Breakdown, by Technology
11.1.2.2.4 Brazil: Rapid Test Kits Market Breakdown, by Application
11.1.2.2.4.1 Brazil: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.2.5 Brazil: Rapid Test Kits Market Breakdown, by End User
11.1.2.3 Argentina
11.1.2.3.1 Overview
11.1.2.4 Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.4.1 Argentina: Rapid Test Kits Market Breakdown, by Type
11.1.2.4.2 Argentina: Rapid Test Kits Market Breakdown, by Product
11.1.2.4.3 Argentina: Rapid Test Kits Market Breakdown, by Technology
11.1.2.4.4 Argentina: Rapid Test Kits Market Breakdown, by Application
11.1.2.4.4.1 Argentina: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.4.5 Argentina: Rapid Test Kits Market Breakdown, by End User
11.1.2.5 Rest of South & Central America
11.1.2.5.1 Overview
11.1.2.6 Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.2.6.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Type
11.1.2.6.2 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Product
11.1.2.6.3 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Technology
11.1.2.6.4 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Application
11.1.2.6.4.1 Rest of South & Central America: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.2.6.5 Rest of South & Central America: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Abbott Laboratories
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Trinity Biotech Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Bio-Rad Laboratories Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Hologic Inc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 DiaSorin SpA
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Premier Medical Corp Pvt Ltd
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Beckman Coulter Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America: Parenteral Nutrition Market, By Key Country - Revenue (2022) (US$ Million)
Figure 30. South & Central America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Brazil: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Argentina: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Rest of South & Central America: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Trinity Biotech Plc
12. Bio-Rad Laboratories Inc
13. Hologic Inc
14. Premier Medical Corp Pvt Ltd
15. DiaSorin SpA
16. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.